Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo - Wikidata - awgldk - TriplyDB

Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo

Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo

http://www.wikidata.org/entity/Q36658987

about

AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase Human resistin promotes neutrophil proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injury Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function.AMPK-NF-κB axis in the photoreceptor disorder during retinal inflammation GSK3β-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury.Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism Participation of proteasome-ubiquitin protein degradation in autophagy and the activation of AMP-activated protein kinase.AICAR attenuates organ injury and inflammatory response after intestinal ischemia and reperfusion.AMP-activated protein kinase and Glycogen Synthase Kinase 3β modulate the severity of sepsis-induced lung injury.AMP-dependent kinase inhibits oxidative stress-induced caveolin-1 phosphorylation and endocytosis by suppressing the dissociation between c-Abl and Prdx1 proteins in endothelial cells Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury.Activation of AMPK enhances neutrophil chemotaxis and bacterial killing.Conceptual approaches for treatment of phosgene inhalation-induced lung injury.Nutrient Excess in AMPK Downregulation and Insulin Resistance.Regulation of pulmonary endothelial barrier function by kinases.Urinary trypsin inhibitor attenuates LPS-induced endothelial barrier dysfunction by upregulation of vascular endothelial-cadherin expression.EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho/ROCK signaling pathway.Rtp801 suppression of epithelial mTORC1 augments endotoxin-induced lung inflammation.Connecting metabolism to intestinal barrier function: The role of leptin.Huang Qi Jian Zhong Pellet Attenuates TNBS-Induced Colitis in Rats via Mechanisms Involving Improvement of Energy Metabolism.Impaired AMPK Activity Drives Age-Associated Acute Lung Injury after Hemorrhage.Frontline Science: D1 dopaminergic receptor signaling activates the AMPK-bioenergetic pathway in macrophages and alveolar epithelial cells and reduces endotoxin-induced ALI.

P2860

Q28547602-F61AB92C-3BB4-4FA8-B3FF-2CF349869E3E Q33600997-61E59590-4317-4BA2-ADD7-585442BBE515 Q33759967-257D131F-2D05-4308-9145-F66D81964685 Q33928244-C203888C-7372-4160-8248-D9D8B6C8B92C Q34519373-0A9086EC-C41A-403B-AB3A-421082AB3283 Q35169945-CC578D26-F557-43E2-A21C-DD65AFCA8C34 Q35235799-0B550820-6598-4F41-A455-10F36DA4D28F Q35434934-518B2FCB-46E8-48AC-97E7-520F983979F1 Q36757995-42F75411-EDDA-42AE-B90D-EE660BF44482 Q37012510-30845E74-CD94-453A-9485-A9DEE16218EF Q37440481-1CFE182B-C4FA-47C7-8001-95DBC23807FB Q37446058-C5563D80-5FFF-4F36-87EE-0BCA9D1AB8FA Q38420382-064881ED-F384-4888-BDB2-28B1F7A8B1AB Q38539754-E78C69DB-842D-405C-8CDA-F9FB8A8CD504 Q38963349-2DA021CA-AD57-45E8-B2F8-2A3B1157E21B Q40197900-FE9DFF52-C26C-4533-BE9E-D7720EA33F3C Q41612549-74FB0453-01CF-4463-92AE-7DCC4B43F067 Q41821017-CAB3EDB9-78A1-488C-8AE0-1806114C7635 Q42118938-4DCCC856-7427-4567-B708-ECC6BCDB7673 Q43118306-3C350B15-F87C-487C-A5A4-7170977660F7 Q47906023-877A3F1C-0F7E-4C40-9F20-896586FAFE60 Q51401647-D721357C-893A-425D-BA91-2CFFC03CCC2E

P2860

Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo

http://www.wikidata.org/entity/Q36658987

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Inhibition of AMP-activated pr ...... nction and lung injury in vivo

@ast

Inhibition of AMP-activated pr ...... nction and lung injury in vivo

@en

type

label

Inhibition of AMP-activated pr ...... nction and lung injury in vivo

@ast

Inhibition of AMP-activated pr ...... nction and lung injury in vivo

@en

prefLabel

Inhibition of AMP-activated pr ...... nction and lung injury in vivo

@ast

Inhibition of AMP-activated pr ...... nction and lung injury in vivo

@en

P1433

Q36658987-DEC829AA-5042-4BE4-871E-45CB485DFBD4

P1476

Q36658987-B3B2F18E-A875-48C1-B9B6-3AD1DE99B3F1

P2093

Q36658987-043120EB-6A88-411D-81CE-2F9AE6E94CF5

Q36658987-0F6F80F1-E308-4DE2-97B7-09E0CB555EBB

Q36658987-55786776-FF28-4AF2-919E-CABA8323459A

Q36658987-846A5E1E-305E-44B5-9E60-266F07D99256

Q36658987-CA1145B7-6C29-4A00-856D-587AF5FEA6B4

P2860

Q36658987-05200B7A-B3F7-44BE-B415-67143F3A3968

Q36658987-19A45DA8-93E2-4695-B85C-8B11687CC882

Q36658987-27CBC32F-F127-4352-9151-94BD6128903E

Q36658987-2B1D209A-0257-4547-8FBF-69F9B647D564

Q36658987-2D364C1B-C26F-41A8-8D02-1118DF7E426F

Q36658987-30BF7A98-2B61-4A7D-8307-BB54C6B0A5A8

Q36658987-371CC353-8E2D-4EBA-A4ED-B2C0EC1E0F3D

Q36658987-373ED84E-E6F8-4BAB-9B18-7DB1837D1D03

Q36658987-37982B0F-E5A0-4344-AB2F-530E490A0083

Q36658987-41E15952-F9F2-4BCE-89D5-6956F7443A72

P304

Q36658987-B1F43CB7-5E7C-4588-AC9D-00453E6C0E4F

P31

Q36658987-2294B411-7D30-466F-9EC1-CBF92A6B2E50

P356

Q36658987-611053CC-E849-41ED-B914-FE1E2B9F7BB5

P407

Q36658987-6902740E-0BBA-4825-9E15-BB87E5C8A820

P433

Q36658987-6489152F-10DD-44E5-ACF3-E14F965D8182

P478

Q36658987-78E2F70E-C658-4DA0-B268-CD7994F50EE6

P50

Q36658987-0AEA32C4-8EED-4CAA-B5FF-D01947C6FFEE

P577

Q36658987-3E539A69-02E5-4B03-A322-159A78BA7818

P5875

Q36658987-6442EC9A-7E4A-43EB-B393-A36C216A357A

P698

Q36658987-3317A111-5080-4123-B39B-ABAE91ECB16C

P921

Q36658987-37C21265-7892-4347-B5D7-D434A73CA7B6

Q36658987-C6A280E5-BD3A-49CC-8920-D3DE06B89359

P932

Q36658987-EEBE1936-BA17-4C11-AA01-8FCE8283106A

P356

J.AJPATH.2012.11.022

P1433

The American Journal of Pathology

P1476

Inhibition of AMP-activated pr ...... nction and lung injury in vivo

@en

P2093

Cate Moriasi

http://www.w3.org/2001/XMLSchema#string

Junjie Xing

http://www.w3.org/2001/XMLSchema#string

Kathleen Coughlan

http://www.w3.org/2001/XMLSchema#string

Ming-Hui Zou

http://www.w3.org/2001/XMLSchema#string

Qilong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity

Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo.

The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1.

Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.

Kruppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier function

Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions.

Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1.

Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine

Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.

Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo

P304

1021-1030

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2012.11.022

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234104289

http://www.w3.org/2001/XMLSchema#string

P698

23306156

http://www.w3.org/2001/XMLSchema#string

P921

lipopolysaccharide

P932

3589075

http://www.w3.org/2001/XMLSchema#string